

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>IL-1 in osteoarthritis: time for a critical... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-934/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-934" />
    
            <meta name="description" content="Read the original article in full on F1000Research: IL-1 in osteoarthritis: time for a critical review of the literature" />
    
            <meta name="og:title" content="F1000Research Article: IL-1 in osteoarthritis: time for a critical review of the literature.">
            <meta name="og:description" content="Read the latest article version by Tonia L. Vincent, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="20635">
            <meta name="article-id" content="18831">
            <meta name="dc.title" content="IL-1 in osteoarthritis: time for a critical review of the literature">
            <meta name="dc.description" content="The concept of interleukin-1 (IL-1) as a target in osteoarthritis (OA) has been an attractive one for many years. It is a highly potent inducer of cartilage degradation, causing the induction of mRNA and controlling the bioavailability of disease-relevant proteases such as ADAMTS5 and MMP13. It drives synovitis and can induce other disease-relevant genes such as nerve growth factor, a key pain sensitiser in OA. However, the quality of evidence for its involvement in disease is modest. Descriptive studies have demonstrated expression of IL-1&alpha; and &beta; in OA cartilage and elevated levels in the synovial fluid of some patients. Agnostic transcriptomic and genomic analyses do not identify IL-1 as a key pathway. In vivo models show a conflicting role for this molecule; early studies using therapeutic approaches in large animal models show a benefit, but most murine studies fail to demonstrate protection where the ligands (IL-1&alpha;/&beta;), the cytokine activator (IL-1&ndash;converting enzyme), or the receptor (IL-1R) have been knocked out. Recently, a number of large double-blind randomised controlled clinical studies targeting IL-1 have failed. Enthusiasm for IL-1 as a target in OA is rapidly dwindling.">
            <meta name="dc.subject" content="Interleukin-1, catabolin, osteoarthritis, cartilage">
            <meta name="dc.creator" content="Vincent, Tonia L.">
            <meta name="dc.date" content="2019/06/21">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.18831.1">
            <meta name="dc.source" content="F1000Research 2019 8:934">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Interleukin-1">
            <meta name="prism.keyword" content="catabolin">
            <meta name="prism.keyword" content="osteoarthritis">
            <meta name="prism.keyword" content="cartilage">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/06/21">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="934">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.18831.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-934">
            <meta name="citation_title" content="IL-1 in osteoarthritis: time for a critical review of the literature">
            <meta name="citation_abstract" content="The concept of interleukin-1 (IL-1) as a target in osteoarthritis (OA) has been an attractive one for many years. It is a highly potent inducer of cartilage degradation, causing the induction of mRNA and controlling the bioavailability of disease-relevant proteases such as ADAMTS5 and MMP13. It drives synovitis and can induce other disease-relevant genes such as nerve growth factor, a key pain sensitiser in OA. However, the quality of evidence for its involvement in disease is modest. Descriptive studies have demonstrated expression of IL-1&alpha; and &beta; in OA cartilage and elevated levels in the synovial fluid of some patients. Agnostic transcriptomic and genomic analyses do not identify IL-1 as a key pathway. In vivo models show a conflicting role for this molecule; early studies using therapeutic approaches in large animal models show a benefit, but most murine studies fail to demonstrate protection where the ligands (IL-1&alpha;/&beta;), the cytokine activator (IL-1&ndash;converting enzyme), or the receptor (IL-1R) have been knocked out. Recently, a number of large double-blind randomised controlled clinical studies targeting IL-1 have failed. Enthusiasm for IL-1 as a target in OA is rapidly dwindling.">
            <meta name="citation_description" content="The concept of interleukin-1 (IL-1) as a target in osteoarthritis (OA) has been an attractive one for many years. It is a highly potent inducer of cartilage degradation, causing the induction of mRNA and controlling the bioavailability of disease-relevant proteases such as ADAMTS5 and MMP13. It drives synovitis and can induce other disease-relevant genes such as nerve growth factor, a key pain sensitiser in OA. However, the quality of evidence for its involvement in disease is modest. Descriptive studies have demonstrated expression of IL-1&alpha; and &beta; in OA cartilage and elevated levels in the synovial fluid of some patients. Agnostic transcriptomic and genomic analyses do not identify IL-1 as a key pathway. In vivo models show a conflicting role for this molecule; early studies using therapeutic approaches in large animal models show a benefit, but most murine studies fail to demonstrate protection where the ligands (IL-1&alpha;/&beta;), the cytokine activator (IL-1&ndash;converting enzyme), or the receptor (IL-1R) have been knocked out. Recently, a number of large double-blind randomised controlled clinical studies targeting IL-1 have failed. Enthusiasm for IL-1 as a target in OA is rapidly dwindling.">
            <meta name="citation_keywords" content="Interleukin-1, catabolin, osteoarthritis, cartilage">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Tonia L. Vincent">
            <meta name="citation_author_institution" content="Centre for OA Pathogenesis Versus Arthritis, Kennedy Institute of Rheumatology, University of Oxford, Oxford, OX3 7FY, UK">
            <meta name="citation_publication_date" content="2019/06/21">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="934">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.18831.1">
            <meta name="citation_firstpage" content="934">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-934/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-934.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=20635 /> <input type=hidden id=articleId name=articleId value=18831 /> <input type=hidden id=xmlUrl value="/articles/8-934/v1/xml"/> <input type=hidden id=xmlFileName value="-8-934-v1.xml"> <input type=hidden id=article_uuid value=13040baa-4d50-4d03-8965-880ced5493e8 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="IL-1 in osteoarthritis: time for a critical review of the literature"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.18831.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.18831.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-934"
  },
  "headline": "IL-1 in osteoarthritis: time for a critical review of the literature",
  "datePublished": "2019-06-21T14:03:38",
  "dateModified": "2019-06-21T14:03:38",
  "author": [
    {
      "@type": "Person",
      "name": "Tonia L. Vincent"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The concept of interleukin-1 (IL-1) as a target in osteoarthritis (OA) has been an attractive one for many years. It is a highly potent inducer of cartilage degradation, causing the induction of mRNA and controlling the bioavailability of disease-relevant proteases such as ADAMTS5 and MMP13. It drives synovitis and can induce other disease-relevant genes such as nerve growth factor, a key pain sensitiser in OA. However, the quality of evidence for its involvement in disease is modest. Descriptive studies have demonstrated expression of IL-1&alpha; and &beta; in OA cartilage and elevated levels in the synovial fluid of some patients. Agnostic transcriptomic and genomic analyses do not identify IL-1 as a key pathway. In vivo models show a conflicting role for this molecule; early studies using therapeutic approaches in large animal models show a benefit, but most murine studies fail to demonstrate protection where the ligands (IL-1&alpha;/&beta;), the cytokine activator (IL-1&ndash;converting enzyme), or the receptor (IL-1R) have been knocked out. Recently, a number of large double-blind randomised controlled clinical studies targeting IL-1 have failed. Enthusiasm for IL-1 as a target in OA is rapidly dwindling."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-934/v1",
            "name": "IL-1 in osteoarthritis: time for a critical review of the literature"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> IL-1 in osteoarthritis: time for a critical review of the literature </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=20635 data-id=18831 data-downloads="" data-views="" data-scholar="10.12688/f1000research.18831.1" data-recommended="" data-doi="10.12688/f1000research.18831.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-934/v1/pdf?article_uuid=13040baa-4d50-4d03-8965-880ced5493e8" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-18831-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-18831-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-18831-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Vincent TL. IL-1 in osteoarthritis: time for a critical review of the literature [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):934 (<a class=new-orange href="https://doi.org/10.12688/f1000research.18831.1" target=_blank>https://doi.org/10.12688/f1000research.18831.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-18831-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=18831 id=track-article-signin-18831 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/18831?target=/articles/8-934/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=20635 /> <input name=articleId type=hidden value=18831 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>IL-1 in osteoarthritis: time for a critical review of the literature</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:tonia.vincent@kennedy.ox.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Tonia L. Vincent</span></a><a href="https://orcid.org/0000-0002-3412-5712" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3412-5712</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:tonia.vincent@kennedy.ox.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Tonia L. Vincent</span></a><a href="http://orcid.org/0000-0002-3412-5712" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3412-5712</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 21 Jun 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.18831.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Centre for OA Pathogenesis Versus Arthritis, Kennedy Institute of Rheumatology, University of Oxford, Oxford, OX3 7FY, UK<br/> <p> <div class=margin-bottom> Tonia L. Vincent <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=52630-49915></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=52629-49916></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The concept of interleukin-1 (IL-1) as a target in osteoarthritis (OA) has been an attractive one for many years. It is a highly potent inducer of cartilage degradation, causing the induction of mRNA and controlling the bioavailability of disease-relevant proteases such as ADAMTS5 and MMP13. It drives synovitis and can induce other disease-relevant genes such as nerve growth factor, a key pain sensitiser in OA. However, the quality of evidence for its involvement in disease is modest. Descriptive studies have demonstrated expression of IL-1 and  in OA cartilage and elevated levels in the synovial fluid of some patients. Agnostic transcriptomic and genomic analyses do not identify IL-1 as a key pathway. <i>In vivo</i> models show a conflicting role for this molecule; early studies using therapeutic approaches in large animal models show a benefit, but most murine studies fail to demonstrate protection where the ligands (IL-1/), the cytokine activator (IL-1converting enzyme), or the receptor (IL-1R) have been knocked out. Recently, a number of large double-blind randomised controlled clinical studies targeting IL-1 have failed. Enthusiasm for IL-1 as a target in OA is rapidly dwindling. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Interleukin-1, catabolin, osteoarthritis, cartilage </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Tonia L. Vincent (<a href="mailto:tonia.vincent@kennedy.ox.ac.uk">tonia.vincent@kennedy.ox.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Tonia L. Vincent </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The author declares that she has no competing interests other than the fact that she trained under Professor Jeremy Saklatvala who had previously characterised catabolin. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported by a grant from Versus Arthritis (21621). <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2019 Vincent TL. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Vincent TL. IL-1 in osteoarthritis: time for a critical review of the literature [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):934 (<a href="https://doi.org/10.12688/f1000research.18831.1" target=_blank>https://doi.org/10.12688/f1000research.18831.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 21 Jun 2019, <b>8</b>(F1000 Faculty Rev):934 (<a href="https://doi.org/10.12688/f1000research.18831.1" target=_blank>https://doi.org/10.12688/f1000research.18831.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 21 Jun 2019, <b>8</b>(F1000 Faculty Rev):934 (<a href="https://doi.org/10.12688/f1000research.18831.1" target=_blank>https://doi.org/10.12688/f1000research.18831.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d15654e143>Introduction</h2><p class="" id=d15654e146>Evidence to support a molecular role in disease is usually amassed from a combination of biological plausibility, demonstration of disease-relevant activity <i>in vitro</i>, descriptive studies in disease tissue samples and genetic analyses. The quality of evidence is improved when it is possible to perform functional validation studies in relevant animal models in which the molecule is knocked down (or out) or to use drugs that target the molecule in question. Ultimately, definitive clinical studies will reveal the success of ones endeavours but with the caveat that you have selected your patient group appropriately and have sensitive and relevant outcome measures. In practice, it is hard to build a robust case to justify the large investment required to support a clinical trial and this is further complicated by publication bias and uncritical analysis. In this commentary, I review the evidence for interleukin-1 (IL-1), arguably the best-investigated cytokine in osteoarthritis (OA) pathogenesis, and take a critical look at the quality of evidence that supports its role in disease. This is not intended to be an exhaustive review of all the literature on IL-1 in OA. Rather, I have selected key articles that add substantially to our knowledge irrespective of whether they report positive or negative outcomes.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15654e155>Interleukin-1, the history</h2><p class="" id=d15654e158>The term IL-1 was first ascribed to a potent cytokine activity that was generated by activated macrophages, and shown to activate T cells<sup><a href="#ref-1">1</a><a href="#ref-3">3</a></sup>. This molecule was initially termed lymphocyte-activating factor but was reclassified to IL-1 in 1979<sup><a href="#ref-4">4</a></sup>. Over the following 15 years, a number of other cell activities were ascribed to IL-1. These included mononuclear cell factor<sup><a href="#ref-5">5</a></sup> and endogenous (or leukocytic) pyrogen, the latter being able to induce fever by direct stimulation of the hypothalamus<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. Immune cells were not the only focus of this early work. Connective tissue cells were also shown to make and respond to an IL-1like activity<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>, the most striking of which was termed catabolin<sup><a href="#ref-10">10</a></sup> (<a href="#T1">Table 1</a>).</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Cellular activities eventually attributed to IL-1.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d15654e209 class=n-a></a><thead><a name=d15654e211 class=n-a></a><tr><a name=d15654e213 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d15654e215 class=n-a></a>Interleukin-1 (IL-1) synonym</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15654e218 class=n-a></a>Role</th></tr></thead><tbody><a name=d15654e223 class=n-a></a><tr><a name=d15654e225 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e227 class=n-a></a>Leukocyte-activating factor </td><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e230 class=n-a></a>T-cell activation</td></tr><tr><a name=d15654e234 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e236 class=n-a></a>Mononuclear cell factor </td><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e239 class=n-a></a>IL-2 induction</td></tr><tr><a name=d15654e243 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e245 class=n-a></a>Catabolin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e248 class=n-a></a>Cartilage degradation<br class=br>Synovitis</td></tr><tr><a name=d15654e254 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e256 class=n-a></a>Endogenous pyrogen/<br class=br>Leukocyte pyrogen </td><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e261 class=n-a></a>Fever</td></tr></tbody></table></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15654e271>Biological plausibility</h2><p class="" id=d15654e274>Catabolin was initially described in co-cultures of synovium with articular cartilage<sup><a href="#ref-11">11</a></sup> and subsequently purified and characterised from non-adherent porcine leukocytes (principally lymphocytes)<sup><a href="#ref-10">10</a>,<a href="#ref-12">12</a><a href="#ref-14">14</a></sup>. It caused profound loss of proteoglycan from cartilage <i>in vitro</i> and <i>in vivo</i> which was deemed to be due to catabolic activity, as well as suppression of new proteoglycan synthesis<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. The catabolic activity that was demonstrated in chondrocytes was indirect as dead cartilage was non-responsive to catabolin, and it was postulated that catabolin induced the enzymes responsible for aggrecan degradation. For a time, there was a consensus that this IL-1like activity was not IL-1 as the isoelectric point (pI) of catabolin was acidic (4.85.0) compared with IL-1, which had a pI of between 6.5 and 7. Subsequent purifications by several groups in mouse, human and pig revealed two distinct molecular species, which have similar biological activities<sup><a href="#ref-17">17</a></sup>. When these molecules were eventually cloned, they turned out to have only modest amino acid sequence homology (20%) and distinct pIs. They were termed IL-1 and IL-1, reflecting the acidic and basic proteins respectively<sup><a href="#ref-17">17</a>,<a href="#ref-18">18</a></sup>. Both ligands bound to the same two-chain receptor (IL-1R) with high affinity (k<sub>d</sub> = 10<sup>10</sup>)<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. Another molecule with some shared homology with IL-1 and IL-1 was discovered. This turned out to be the IL-1R antagonist (IL-1Ra), a natural inhibitor of IL-1 signalling<sup><a href="#ref-21">21</a><a href="#ref-23">23</a></sup>.</p><p class="" id=d15654e336>IL-1 and IL-1 are made as pro-proteins which lack signal peptides and are retained in the cytoplasm<sup><a href="#ref-24">24</a></sup>. Unlike proIL-1, proIL-1 lacks biological activity and must be processed by caspase 1, also known as IL-1converting enzyme (ICE)<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>. Processing by caspase 1 is linked to secretion of IL-1 and this therefore is a requirement for its biological effects. IL-18 is processed in a similar fashion. These effects are dependent upon activation of the inflammasome complex and indicate that IL-1 biological activity requires a two-hit process: induction of the mRNA followed by processing of the pro-molecule prior to secretion from the cell<sup><a href="#ref-27">27</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15654e357> <i>In vitro</i> disease-relevant activity</h2><p class="" id=d15654e363>IL-1 was hugely influential in the discovery of the proteases responsible for cartilage degradation in OA. IL-1 was able to induce a number of known matrix metalloproteinases (MMPs) <i>in vitro</i> and suppress proteoglycan synthesis<sup><a href="#ref-9">9</a>,<a href="#ref-16">16</a>,<a href="#ref-28">28</a><a href="#ref-30">30</a></sup> but it was not until the large-scale purification of medium from IL-1stimulated cartilage that the first aggrecanase (a disintegrin with thrombospondin motif 4, or ADAMTS4) was identified<sup><a href="#ref-31">31</a></sup>. By homology searching, this led to the identification of ADAMTS5<sup><a href="#ref-18">18</a></sup>. The role of ADAMTS5, but not ADAMTS4, in OA pathogenesis was subsequently shown by Glasson <i>et al</i>. in mice (2005)<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>. There are conflicting views on whether ADAMTS5 and ADAMTS4 are both pathogenic mediators in human OA<sup><a href="#ref-21">21</a>,<a href="#ref-23">23</a></sup>. Interestingly, in most species, ADAMTS5 is constitutively expressed and is not much regulated by IL-1 at the mRNA level<sup><a href="#ref-34">34</a></sup>, even though its activity is strongly IL-1regulated<sup><a href="#ref-21">21</a></sup>. Regulation of activity is thought to be controlled by the re-uptake of ADAMTS5 at the cell surface by the scavenger receptor LRP1<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. It is worth noting that IL-1 is used as an exemplar in these studies and is ideally suited because of its potency and understood mechanisms of action. Other cytokines, including tumour necrosis factor (TNF)<sup><a href="#ref-37">37</a></sup>, retinoic acid<sup><a href="#ref-34">34</a>,<a href="#ref-38">38</a></sup> and oncostatin M<sup><a href="#ref-39">39</a></sup>, also are strong inducers of cartilage catabolism <i>in vitro</i>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15654e445>Interleukin-1 regulation in human osteoarthritis tissues</h2><p class="" id=d15654e448>A standard initial approach to validation of candidate molecules in disease almost always involves the demonstration that the molecule is upregulated in diseased tissues. This is challenging in OA in particular because of difficulties in obtaining normal tissue as a comparator. IL-1 is highly potent and usually present at very low concentrations. It is not easy to detect by conventional enzyme-linked immunosorbent assay or even by higher-sensitivity assays such as the MesoScale Discovery platform<sup><a href="#ref-40">40</a></sup>. However, using high-sensitivity assays, some groups have detected low levels (&lt;1 pM) of IL-1 in the synovial fluid of some patients with OA and rarely in normal joints<sup><a href="#ref-41">41</a></sup>. There are studies reporting positive immunohistochemistry for IL-1 and IL-1 and ICE as well as <i>in situ</i> hybridisation data for ICE in established human OA cartilage<sup><a href="#ref-42">42</a>,<a href="#ref-43">43</a></sup>. However, these studies compare expression levels within OA tissue and do not compare with normal tissue. These controls are especially important when we consider that IL-1 is made as a pro-enzyme and that intracellular staining does not correlate with secretion and activity. Moreover, work from our group previously showed that simple mechanical injury (that occurs at the time of tissue dissection) is a strong inducer of proIL-1 in normal healthy tissue and could easily confound the analysis<sup><a href="#ref-44">44</a></sup> (<a href="#T2">Table 2</a>).</p><a name=T2 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 2. Evidence for a role of IL-1 in osteoarthritis.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d15654e488 class=n-a></a><thead><a name=d15654e490 class=n-a></a><tr><a name=d15654e492 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d15654e494 class=n-a></a>Type of evidence</th><th align=left colspan=1 rowspan=1 valign=top><a name=d15654e497 class=n-a></a>Quality of evidence (likely role<br class=br>in disease)</th></tr></thead><tbody><a name=d15654e504 class=n-a></a><tr><a name=d15654e506 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e508 class=n-a></a>Biological plausibility</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e511 class=n-a></a>High</td></tr><tr><a name=d15654e515 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e517 class=n-a></a> <i>In vitro</i> disease-relevant activity</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e523 class=n-a></a>High</td></tr><tr><a name=d15654e527 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e529 class=n-a></a>Human osteoarthritis tissue<br class=br>studies</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e534 class=n-a></a>Low (not identified by agnostic<br class=br>-omic analyses)</td></tr><tr><a name=d15654e540 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e542 class=n-a></a>Pre-clinical knockout studies</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e545 class=n-a></a>Moderate (conflicting role in<br class=br>disease)</td></tr><tr><a name=d15654e551 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e553 class=n-a></a>Human clinical studies</td><td align=left colspan=1 rowspan=1 valign=top><a name=d15654e556 class=n-a></a>High (little role in disease)</td></tr></tbody></table></div><p class="" id=d15654e563>Counting the IL-1positive cells within the synovium of patients with OA and rheumatoid arthritis (RA) demonstrates that OA synovial cells are much less likely to be positive (20%) than RA cells (60%)<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a>,<a href="#ref-45">45</a></sup>. In several similar studies, OA tissue is generally regarded as the negative control, so again normal tissue is not included.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15654e580>Molecular studies</h2><p class="" id=d15654e583>Microarray studies potentially allow one to examine regulated genes in disease in an unbiased fashion. Early array studies in OA cartilage did not demonstrate elevation of <i>IL-1</i> mRNA in OA compared with normal cartilage<sup><a href="#ref-46">46</a></sup> or in lesional compared with non-lesional OA tissue<sup><a href="#ref-47">47</a></sup>. In a larger study by Aigner <i>et al</i>., who studied 4000 genes in 78 patient and control samples, <i>IL-1</i> was downregulated in disease by around 50%<sup><a href="#ref-48">48</a></sup>. Two recent RNA sequencing (RNA-Seq) analyses deserve special mention. One study, by Soul <i>et al</i>., performed RNA-Seq on the articular cartilage of patients undergoing knee replacement surgery and compared gene expression with non-disease cartilage in the same joint<sup><a href="#ref-49">49</a></sup>. An unbiased analysis identified two molecularly distinct groups within the affected OA samples. Pathway analysis revealed over-representation of complement activation pathways, innate immune responses, Wnt and transforming growth factor beta (TGF) signalling. There was a notable absence of an inflammatory cytokine signature<sup><a href="#ref-49">49</a></sup>. The first single-cell RNA-Seq study in OA articular cartilage was recently published<sup><a href="#ref-50">50</a></sup>. Although this study did not have normal cartilage as a comparator, <i>IL-1</i> did not feature as a marker for one of the seven phenotypically distinct groups of OA chondrocytes. Nor was it associated with a molecular signature that predicted disease progression<sup><a href="#ref-50">50</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15654e634>Genetics</h2><p class="" id=d15654e637>There are replicated candidate studies in which polymorphic variants of <i>IL-1</i> have been shown to be increased in OA compared with a non-OA population (reviewed in <a href="#ref-51">51</a>), but <i>IL-1</i> has not come out of any of the genome-wide association studies which have looked agnostically across the genome either by mapping polymorphic variants or by whole genome sequencing. The largest of these studies, recently published by the Zeggini group, identified 64 disease loci (52 of them novel) from over 77,000 large-joint OA cases<sup><a href="#ref-52">52</a></sup>. Of these, four strong groups emerge: (1) <i>TGF</i> family members, including candidate genes <i>GDF5, TGF1, LTBP1, LTBP</i>3 and <i>SMAD3</i>; (2) <i>TGF</i>, which has strong independent pre-clinical data to support it as a target<sup><a href="#ref-53">53</a></sup>; (3) fibroblast growth factors (FGFs), in particular <i>FGF18</i> and its receptor <i>FGFR3</i>; FGF18, is showing significant promise following intra-articular injection in clinical trial<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup> and (4) <i>ALDH1A2</i>, encoding the enzyme that synthesises retinoic acid, a strong genome-wide association study hit in hand OA<sup><a href="#ref-56">56</a></sup> and now in knee. Again, the absence of an inflammatory cytokine signature is noteworthy.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15654e694>Pre-clinical studies</h2><p class="" id=d15654e697>Prior to the genetic modification era, pre-clinical OA was largely restricted to large animals (for example, dog and rabbit). A few studies looked at therapeutic targeting of IL-1 using either recombinant IL-1Ra (anakinra) or gene transfer of IL-1Ra. All of these early studies showed striking protection in rapidly progressive surgical models of OA when treatment was initiated early after surgery<sup><a href="#ref-57">57</a><a href="#ref-59">59</a></sup>. Similar protection was seen in rats after anterior cruciate ligament transection when treated early with recombinant intra-articular IL-1Ra<sup><a href="#ref-60">60</a></sup>. DLima <i>et al</i>. showed that caspase 1 inhibition suppressed disease in rabbits after cruciate ligament transection when delivered three times per week for 9 weeks<sup><a href="#ref-61">61</a></sup>. The latter study could be affecting molecules other than IL-1, such as IL-18.</p><p class="" id=d15654e718>The first surgical models of OA in genetically modified mice were performed in 2003 by Clements <i>et al</i>.<sup><a href="#ref-62">62</a></sup>. In that study, partial meniscectomy was performed in four genetically modified strains: <i>Il1b</i> knockout, <i>Ice</i> knockout, <i>Mmp3</i> knockout and nitric oxide synthase (<i>Nos</i>) knockout mice. None of these strains demonstrated reduced disease; if anything, a modest increase in disease was observed<sup><a href="#ref-62">62</a></sup>. Kawaguchis group also reported (although data were not included in the article) a lack of protection in <i>Il1a/Il1b</i> double-knockout mice<sup><a href="#ref-63">63</a></sup>. Our own group has failed to see protection in <i>Il1r1</i> knockout mice (unpublished data). Only one report of protection in the <i>Il1b</i> knockout mouse has been published and this was in a review article<sup><a href="#ref-64">64</a></sup>, in which a 40% reduction in disease at one time point (8 weeks) was observed. The number of animals used in this experiment was not specified.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15654e766>Human clinical studies</h2><p class="" id=d15654e769>One assumes that positive results in small open-label clinical studies<sup><a href="#ref-65">65</a></sup> are partly responsible for driving the decision to proceed to randomised controlled trials (RCTs) in OA using IL-1 targeting therapies. These have included, most recently, two large studies by Abbvie using a dual neutralising antibody against IL-1 and IL-1 in hand OA<sup><a href="#ref-66">66</a></sup> and knee OA<sup><a href="#ref-67">67</a></sup>. Both studies failed to reach their primary outcome target and concluded lack of efficacy. Similarly, a single intra-articular injection of anakinra failed to show clinical efficacy at 3 months, the primary endpoint, in an RCT of 160 individuals with knee OA<sup><a href="#ref-68">68</a></sup>. A randomised double-blind controlled study of an IL-1R neutralising antibody also failed to meet the primary endpoint<sup><a href="#ref-69">69</a></sup>. Two small studies, one open-label and one placebo-controlled, demonstrated reduction in pain in individuals after knee trauma with IL-1Ra (anakinra). It is important to stress that whilst knee trauma may lead to OA over the course of 5 to 10 years in 50% of cases<sup><a href="#ref-70">70</a></sup>, there is no evidence that early pain after injury is indicative of OA or that inhibiting IL-1 early after injury can prevent OA developing<sup><a href="#ref-71">71</a>,<a href="#ref-72">72</a></sup>.</p><div class=section><a name=d15654e804 class=n-a></a><h3 class=section-title>Co-existing crystal arthropathy</h3><p class="" id=d15654e809>Could IL-1 still have a role in a subset of patients with OA? One reasonable hypothesis is that some patients disease may be complicated by crystal arthritis. Calcium pyrophosphate (CPP) and basic calcium phosphate (BCP) crystals are present in the synovial fluid of around 20 to 25% of patients with knee OA<sup><a href="#ref-73">73</a></sup> and CPP in 13% of patients with small-joint (hand and wrist) OA<sup><a href="#ref-74">74</a></sup>. Although the presence of crystals in the joint does not necessarily lead to a clinical crystal arthritis, all crystals (including urate, pyrophosphate and cholesterol) are potential activators of the inflammasome pathway, resulting in caspase 1dependent processing of intracellular proIL-1<sup><a href="#ref-75">75</a><a href="#ref-77">77</a></sup>. In one study, urate levels within the synovial fluid correlated strongly with IL-1 (in those samples in which it was measurable) and IL-18<sup><a href="#ref-41">41</a></sup>. Radiographic disease severity correlated with levels of IL-1<sup><a href="#ref-41">41</a></sup>. These results identify synovial fluid urate or IL-1/IL-18 levels (or both) as potential biomarkers of disease severity. The jury is still out on whether IL-1 may be driving pathogenesis in a small subgroup of OA individuals who have an active crystal arthritis contributing to their structural and symptomatic disease<sup><a href="#ref-78">78</a></sup>. In view of the complete lack of signal from the antiIL-1 clinical trials, one has to assume that the proportion of such individuals within the larger OA population is small.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d15654e844>Conclusions</h2><p class="" id=d15654e847>IL-1 remains the most potent inducer of cartilage degradation we know of and from the early days of catabolin has been a top molecular candidate in OA. In recent years, IL-1 has proven to be a good target in diseases due to genetic defects in the inflammasome pathway, including some of the rare periodic fever syndromes, and this has been a good opportunity to validate the available therapies<sup><a href="#ref-79">79</a></sup>. IL-1 targeting is also efficacious and licenced for use in crystal arthritis<sup><a href="#ref-80">80</a></sup>, although it is usually reserved for those with severe disease unresponsive to first-line treatments. Randomised clinical trials in OA are conclusively telling us that this is not a target in OA despite all our hopes. Could this have been anticipated earlier? In retrospect, the evidence for IL-1 from the clinical data, especially those acquired from agnostic whole genome and whole transcriptome analyses, was weak. Results from pre-clinical studies were polarised in their conclusions and this calls into question the robustness of these data. Failure to reduce sources of bias e.g. through randomisation of animals, blinding experimentor to treatment group, or double blind scoring, are rarely described and probably not often performed. Studies are often under-powered and may examine outcomes at only one time point. Animal studies in particular are further confounded by a publication bias towards positive results<sup><a href="#ref-81">81</a></sup>. RCTs are an expensive way to disprove a major role for a molecule in disease, but the journey nonetheless brings us closer to understanding OA pathogenesis.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d15654e1 class=n-a></a><h2 class=main-title id=d15885>Grant information</h2><p>This work was supported by a grant from Versus Arthritis (21621).</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d15654e866 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d16156>References</h2><div class="section ref-list"><a name=d15654e866 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d15654e873 class=n-a></a>Gery I, Gershon RK, Waksman BH: Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. <i>J Exp Med.</i> 1972; <b>136</b>(1): 12842. <a target=xrefwindow id=d15654e881 href="http://www.ncbi.nlm.nih.gov/pubmed/5033417">PubMed Abstract </a> | <a target=xrefwindow id=d15654e884 href="https://doi.org/10.1084/jem.136.1.128">Publisher Full Text </a> | <a target=xrefwindow id=d15654e887 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2139184">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d15654e896 class=n-a></a>Mizel SB: Biochemical and biological characterization of lymphocyte-activating factor (LAF) produced by the murine macrophage cell line, P388D. <i>Ann N Y Acad Sci.</i> 1979; <b>332</b>(1): 53949. <a target=xrefwindow id=d15654e904 href="http://www.ncbi.nlm.nih.gov/pubmed/231409">PubMed Abstract </a> | <a target=xrefwindow id=d15654e907 href="https://doi.org/10.1111/j.1749-6632.1979.tb47148.x">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d15654e916 class=n-a></a>Smith KA, Lachman LB, Oppenheim JJ, <i> et al.</i>: The functional relationship of the interleukins. <i>J Exp Med.</i> 1980; <b>151</b>(6): 15516. <a target=xrefwindow id=d15654e927 href="http://www.ncbi.nlm.nih.gov/pubmed/6770028">PubMed Abstract </a> | <a target=xrefwindow id=d15654e930 href="https://doi.org/10.1084/jem.151.6.1551">Publisher Full Text </a> | <a target=xrefwindow id=d15654e934 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2185867">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d15654e943 class=n-a></a>Mizel SB, Farrar JJ: Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors. <i>Cell Immunol.</i> 1979; <b>48</b>(2): 4336. <a target=xrefwindow id=d15654e951 href="http://www.ncbi.nlm.nih.gov/pubmed/92371">PubMed Abstract </a> | <a target=xrefwindow id=d15654e954 href="https://doi.org/10.1016/0008-8749(79)90139-4">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d15654e963 class=n-a></a>Mizel SB, Dayer JM, Krane SM, <i> et al.</i>: Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). <i>Proc Natl Acad Sci U S A.</i> 1981; <b>78</b>(4): 24747. <a target=xrefwindow id=d15654e974 href="http://www.ncbi.nlm.nih.gov/pubmed/6264478">PubMed Abstract </a> | <a target=xrefwindow id=d15654e977 href="https://doi.org/10.1073/pnas.78.4.2474">Publisher Full Text </a> | <a target=xrefwindow id=d15654e981 href="http://www.ncbi.nlm.nih.gov/pmc/articles/319369">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d15654e991 class=n-a></a>van Damme J, De Ley M, Opdenakker G, <i> et al.</i>: Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. <i>Nature.</i> 1985; <b>314</b>(6008): 2668. <a target=xrefwindow id=d15654e1002 href="http://www.ncbi.nlm.nih.gov/pubmed/3920526">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1005 href="https://doi.org/10.1038/314266a0">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d15654e1014 class=n-a></a>Duff GW, Durum SK: Fever and immunoregulation: hyperthermia, interleukins 1 and 2, and T-cell proliferation. <i>Yale J Biol Med.</i> 1982; <b>55</b>(56): 43742. <a target=xrefwindow id=d15654e1022 href="http://www.ncbi.nlm.nih.gov/pubmed/6985107">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1025 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2596539">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d15654e1034 class=n-a></a>Dayer JM, Brard J, Chess L, <i> et al.</i>: Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells. <i>J Clin Invest.</i> 1979; <b>64</b>(5): 138692. <a target=xrefwindow id=d15654e1045 href="http://www.ncbi.nlm.nih.gov/pubmed/227933">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1048 href="https://doi.org/10.1172/JCI109596">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1052 href="http://www.ncbi.nlm.nih.gov/pmc/articles/371287">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d15654e1061 class=n-a></a>Balavoine JF, de Rochemonteix B, Williamson K, <i> et al.</i>: Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). <i>J Clin Invest.</i> 1986; <b>78</b>(4): 11204. <a target=xrefwindow id=d15654e1072 href="http://www.ncbi.nlm.nih.gov/pubmed/3020090">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1075 href="https://doi.org/10.1172/JCI112669">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1079 href="http://www.ncbi.nlm.nih.gov/pmc/articles/423775">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d15654e1088 class=n-a></a>Saklatvala J, Dingle JT: Identification of catabolin, a protein from synovium which induces degradation of cartilage in organ culture. <i>Biochem Biophys Res Commun.</i> 1980; <b>96</b>(3): 122531. <a target=xrefwindow id=d15654e1096 href="http://www.ncbi.nlm.nih.gov/pubmed/7437067">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1099 href="https://doi.org/10.1016/0006-291x(80)90082-0">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d15654e1108 class=n-a></a>Fell HB, Jubb RW: The effect of synovial tissue on the breakdown of articular cartilage in organ culture. <i>Arthritis Rheum.</i> 1977; <b>20</b>(7): 135971. <a target=xrefwindow id=d15654e1116 href="http://www.ncbi.nlm.nih.gov/pubmed/911354">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1119 href="https://doi.org/10.1002/art.1780200710">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d15654e1129 class=n-a></a>Saklatvala J: Characterization of catabolin, the major product of pig synovial tissue that induces resorption of cartilage proteoglycan <i>in vitro</i>. <i>Biochem J.</i> 1981; <b>199</b>(3): 70514. <a target=xrefwindow id=d15654e1140 href="http://www.ncbi.nlm.nih.gov/pubmed/7340826">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1143 href="https://doi.org/10.1042/bj1990705">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1147 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1163428">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d15654e1156 class=n-a></a>Saklatvala J, Sarsfield SJ: Lymphocytes induce resorption of cartilage by producing catabolin. <i>Biochem J.</i> 1982; <b>202</b>(1): 2758. <a target=xrefwindow id=d15654e1164 href="http://www.ncbi.nlm.nih.gov/pubmed/7082313">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1167 href="https://doi.org/10.1042/bj2020275">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1170 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1158104">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d15654e1179 class=n-a></a>Saklatvala J, Curry VA, Sarsfield SJ: Purification to homogeneity of pig leucocyte catabolin, a protein that causes cartilage resorption <i>in vitro</i>. <i>Biochem J.</i> 1983; <b>215</b>(2): 38592. <a target=xrefwindow id=d15654e1190 href="http://www.ncbi.nlm.nih.gov/pubmed/6651767">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1193 href="https://doi.org/10.1042/bj2150385">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1197 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1152407">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d15654e1206 class=n-a></a>Dingle JT, Page Thomas DP, King B, <i> et al.</i>: <i>In vivo</i> studies of articular tissue damage mediated by catabolin/interleukin 1. <i>Ann Rheum Dis.</i> 1987; <b>46</b>(7): 52733. <a target=xrefwindow id=d15654e1220 href="http://www.ncbi.nlm.nih.gov/pubmed/3499123">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1224 href="https://doi.org/10.1136/ard.46.7.527">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1227 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1002187">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d15654e1236 class=n-a></a>Tyler JA: Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. <i>Biochem J.</i> 1985; <b>227</b>(3): 86978. <a target=xrefwindow id=d15654e1244 href="http://www.ncbi.nlm.nih.gov/pubmed/3873936">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1247 href="https://doi.org/10.1042/bj2270869">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1250 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1144916">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d15654e1259 class=n-a></a>Oppenheim JJ, Kovacs EJ, Matsushima K, <i> et al.</i>: There is more than one interleukin 1. <i>Immunol Today.</i> 1986; <b>7</b>(2): 4556. <a target=xrefwindow id=d15654e1270 href="http://www.ncbi.nlm.nih.gov/pubmed/25291552">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1273 href="https://doi.org/10.1016/0167-5699(86)90124-6">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d15654e1283 class=n-a></a>Abbaszade I, Liu RQ, Yang F, <i> et al.</i>: Cloning and characterization of <i>ADAMTS11</i>, an aggrecanase from the ADAMTS family. <i>J Biol Chem.</i> 1999; <b>274</b>(33): 2344350. <a target=xrefwindow id=d15654e1297 href="http://www.ncbi.nlm.nih.gov/pubmed/10438522">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1301 href="https://doi.org/10.1074/jbc.274.33.23443">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d15654e1310 class=n-a></a>Saklatvala J, Bird T: A common class of receptors for the two types of porcine interleukin-1 on articular chondrocytes. <i>Lymphokine Res.</i> 1986; <b>5 Suppl 1</b>: S99104. <a target=xrefwindow id=d15654e1318 href="http://www.ncbi.nlm.nih.gov/pubmed/2946906">PubMed Abstract </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d15654e1327 class=n-a></a>Stylianou E, O'Neill LA, Rawlinson L, <i> et al.</i>: Interleukin 1 induces NF-kappa B through its type I but not its type II receptor in lymphocytes. <i>J Biol Chem.</i> 1992; <b>267</b>(22): 1583641. <a target=xrefwindow id=d15654e1338 href="http://www.ncbi.nlm.nih.gov/pubmed/1386364">PubMed Abstract </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d15654e1347 class=n-a></a>Ismail HM, Yamamoto K, Vincent TL, <i> et al.</i>: Interleukin-1 Acts via the JNK-2 Signaling Pathway to Induce Aggrecan Degradation by Human Chondrocytes. <i>Arthritis Rheumatol.</i> 2015; <b>67</b>(7): 182636. <a target=xrefwindow id=d15654e1358 href="http://www.ncbi.nlm.nih.gov/pubmed/25776267">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1361 href="https://doi.org/10.1002/art.39099">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d15654e1370 class=n-a></a>Dinarello CA: Interleukin-1 and interleukin-1 antagonism. <i>Blood.</i> 1991; <b>77</b>(8): 162752. <a target=xrefwindow id=d15654e1378 href="http://www.ncbi.nlm.nih.gov/pubmed/1826616">PubMed Abstract </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d15654e1387 class=n-a></a>Song RH, Tortorella MD, Malfait AM, <i> et al.</i>: Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. <i>Arthritis Rheum.</i> 2007; <b>56</b>(2): 57585. <a target=xrefwindow id=d15654e1398 href="http://www.ncbi.nlm.nih.gov/pubmed/17265492">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1401 href="https://doi.org/10.1002/art.22334">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d15654e1411 class=n-a></a>Hazuda D, Webb RL, Simon P, <i> et al.</i>: Purification and characterization of human recombinant precursor interleukin 1 beta. <i>J Biol Chem.</i> 1989; <b>264</b>(3): 168993. <a target=xrefwindow id=d15654e1422 href="http://www.ncbi.nlm.nih.gov/pubmed/2643602">PubMed Abstract </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d15654e1431 class=n-a></a>Schroder K, Tschopp J: The inflammasomes. <i>Cell.</i> 2010; <b>140</b>(6): 82132. <a target=xrefwindow id=d15654e1439 href="http://www.ncbi.nlm.nih.gov/pubmed/20303873">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1442 href="https://doi.org/10.1016/j.cell.2010.01.040">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/715197802"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e1451 class=n-a></a>Gross O, Yazdi AS, Thomas CJ, <i> et al.</i>: Inflammasome activators induce interleukin-1 secretion via distinct pathways with differential requirement for the protease function of caspase-1. <i>Immunity.</i> 2012; <b>36</b>(3): 388400. <a target=xrefwindow id=d15654e1462 href="http://www.ncbi.nlm.nih.gov/pubmed/22444631">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1465 href="https://doi.org/10.1016/j.immuni.2012.01.018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/715197802">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d15654e1478 class=n-a></a>Gross O, Thomas CJ, Guarda G, <i> et al.</i>: The inflammasome: an integrated view. <i>Immunol Rev.</i> 2011; <b>243</b>(1): 13651. <a target=xrefwindow id=d15654e1489 href="http://www.ncbi.nlm.nih.gov/pubmed/21884173">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1492 href="https://doi.org/10.1111/j.1600-065X.2011.01046.x">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d15654e1501 class=n-a></a>Gadher SJ, Eyre DR, Duance VC, <i> et al.</i>: Susceptibility of cartilage collagens type II, IX, X, and XI to human synovial collagenase and neutrophil elastase. <i>Eur J Biochem.</i> 1988; <b>175</b>(1): 17. <a target=xrefwindow id=d15654e1512 href="http://www.ncbi.nlm.nih.gov/pubmed/2841121">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1515 href="https://doi.org/10.1111/j.1432-1033.1988.tb14158.x">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d15654e1524 class=n-a></a>van den Berg WB, van de Loo FA, Zwarts WA, <i> et al.</i>: Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study. <i>Ann Rheum Dis.</i> 1988; <b>47</b>(10): 85563. <a target=xrefwindow id=d15654e1535 href="http://www.ncbi.nlm.nih.gov/pubmed/3264138">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1538 href="https://doi.org/10.1136/ard.47.10.855">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1542 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1003616">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d15654e1552 class=n-a></a>Lefebvre V, Peeters-Joris C, Vaes G: Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. <i>Biochim Biophys Acta.</i> 1990; <b>1052</b>(3): 36678. <a target=xrefwindow id=d15654e1560 href="http://www.ncbi.nlm.nih.gov/pubmed/2162214">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1563 href="https://doi.org/10.1016/0167-4889(90)90145-4">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/723292390"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e1572 class=n-a></a>Tortorella MD, Burn TC, Pratta MA, <i> et al.</i>: Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. <i>Science.</i> 1999; <b>284</b>(5420): 16646. <a target=xrefwindow id=d15654e1583 href="http://www.ncbi.nlm.nih.gov/pubmed/10356395">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1586 href="https://doi.org/10.1126/science.284.5420.1664">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/723292390">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1025630"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e1599 class=n-a></a>Glasson SS, Askew R, Sheppard B, <i> et al.</i>: Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. <i>Nature.</i> 2005; <b>434</b>(7033): 6448. <a target=xrefwindow id=d15654e1610 href="http://www.ncbi.nlm.nih.gov/pubmed/15800624">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1613 href="https://doi.org/10.1038/nature03369">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1025630">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d15654e1626 class=n-a></a>Glasson SS, Askew R, Sheppard B, <i> et al.</i>: Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. <i>Arthritis Rheum.</i> 2004; <b>50</b>(8): 254758. <a target=xrefwindow id=d15654e1637 href="http://www.ncbi.nlm.nih.gov/pubmed/15334469">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1640 href="https://doi.org/10.1002/art.20558">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d15654e1649 class=n-a></a>Fosang AJ, Rogerson FM, East CJ, <i> et al.</i>: ADAMTS-5: the story so far. <i>Eur Cell Mater.</i> 2008; <b>15</b>: 1126. <a target=xrefwindow id=d15654e1660 href="http://www.ncbi.nlm.nih.gov/pubmed/18247274">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1663 href="https://doi.org/10.22203/eCM.v015a02">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717965022"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e1672 class=n-a></a>Yamamoto K, Troeberg L, Scilabra SD, <i> et al.</i>: LRP-1-mediated endocytosis regulates extracellular activity of ADAMTS-5 in articular cartilage. <i>FASEB J.</i> 2013; <b>27</b>(2): 51121. <a target=xrefwindow id=d15654e1683 href="http://www.ncbi.nlm.nih.gov/pubmed/23064555">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1686 href="https://doi.org/10.1096/fj.12-216671">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1690 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3545526">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717965022">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727343525"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e1704 class=n-a></a>Yamamoto K, Santamaria S, Botkjaer KA, <i> et al.</i>: Inhibition of Shedding of Low-Density Lipoprotein Receptor-Related Protein 1 Reverses Cartilage Matrix Degradation in Osteoarthritis. <i>Arthritis Rheumatol.</i> 2017; <b>69</b>(6): 124656. <a target=xrefwindow id=d15654e1715 href="http://www.ncbi.nlm.nih.gov/pubmed/28235248">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1718 href="https://doi.org/10.1002/art.40080">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1722 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5449214">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727343525">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d15654e1735 class=n-a></a>Saklatvala J: Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. <i>Nature.</i> 1986; <b>322</b>(6079): 5479. <a target=xrefwindow id=d15654e1743 href="http://www.ncbi.nlm.nih.gov/pubmed/3736671">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1746 href="https://doi.org/10.1038/322547a0">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d15654e1755 class=n-a></a>Campbell MA, Handley CJ, D'Souza SE: Turnover of proteoglycans in articular-cartilage cultures. Characterization of proteoglycans released into the medium. <i>Biochem J.</i> 1989; <b>259</b>(1): 215. <a target=xrefwindow id=d15654e1763 href="http://www.ncbi.nlm.nih.gov/pubmed/2719643">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1766 href="https://doi.org/10.1042/bj2590021">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1769 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1138467">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d15654e1778 class=n-a></a>Morgan TG, Rowan AD, Dickinson SC, <i> et al.</i>: Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases. <i>Ann Rheum Dis.</i> 2006; <b>65</b>(2): 18490. <a target=xrefwindow id=d15654e1789 href="http://www.ncbi.nlm.nih.gov/pubmed/15975972">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1792 href="https://doi.org/10.1136/ard.2004.033480">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1796 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1798019">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d15654e1805 class=n-a></a>Watt FE, Paterson E, Freidin A, <i> et al.</i>: Acute Molecular Changes in Synovial Fluid Following Human Knee Injury: Association With Early Clinical Outcomes. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(9): 212940. <a target=xrefwindow id=d15654e1816 href="http://www.ncbi.nlm.nih.gov/pubmed/26991527">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1819 href="https://doi.org/10.1002/art.39677">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1823 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5006850">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d15654e1832 class=n-a></a>Denoble AE, Huffman KM, Stabler TV, <i> et al.</i>: Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. <i>Proc Natl Acad Sci U S A.</i> 2011; <b>108</b>(5): 208893. <a target=xrefwindow id=d15654e1843 href="http://www.ncbi.nlm.nih.gov/pubmed/21245324">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1846 href="https://doi.org/10.1073/pnas.1012743108">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1850 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3033282">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d15654e1860 class=n-a></a>Moldovan F, Pelletier JP, Jolicoeur FC, <i> et al.</i>: Diacerhein and rhein reduce the ICE-induced IL-1beta and IL-18 activation in human osteoarthritic cartilage. <i>Osteoarthritis and Cartilage.</i> 2000; <b>8</b>(3): 18696. <a target=xrefwindow id=d15654e1871 href="http://www.ncbi.nlm.nih.gov/pubmed/10806046">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1874 href="https://doi.org/10.1053/joca.1999.0289">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d15654e1883 class=n-a></a>Saha N, Moldovan F, Tardif G, <i> et al.</i>: Interleukin-1beta-converting enzyme/caspase-1 in human osteoarthritic tissues: Localization and role in the maturation of interleukin-1beta and interleukin-18. <i>Arthritis Rheum.</i> 1999; <b>42</b>(8): 157787. <a target=xrefwindow id=d15654e1894 href="http://www.ncbi.nlm.nih.gov/pubmed/10446854">PubMed Abstract </a> | <a target="xrefwindow" id="d15654e1897" href="https://doi.org/10.1002/1529-0131(199908)42:8<1577::AID-ANR3&gt;3.0.CO;2-Z">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d15654e1906 class=n-a></a>Gruber J, Vincent TL, Hermansson M, <i> et al.</i>: Induction of interleukin-1 in articular cartilage by explantation and cutting. <i>Arthritis Rheum.</i> 2004; <b>50</b>(8): 253946. <a target=xrefwindow id=d15654e1917 href="http://www.ncbi.nlm.nih.gov/pubmed/15334468">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1920 href="https://doi.org/10.1002/art.20369">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d15654e1929 class=n-a></a>Farahat MN, Yanni G, Poston R, <i> et al.</i>: Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. <i>Ann Rheum Dis.</i> 1993; <b>52</b>(12): 8705. <a target=xrefwindow id=d15654e1940 href="http://www.ncbi.nlm.nih.gov/pubmed/8311538">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1943 href="https://doi.org/10.1136/ard.52.12.870">Publisher Full Text </a> | <a target=xrefwindow id=d15654e1947 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1005218">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d15654e1956 class=n-a></a>Aigner T, Zien A, Gehrsitz A, <i> et al.</i>: Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. <i>Arthritis Rheum.</i> 2001; <b>44</b>(12): 277789. <a target=xrefwindow id=d15654e1967 href="http://www.ncbi.nlm.nih.gov/pubmed/11762938">PubMed Abstract </a> | <a target="xrefwindow" id="d15654e1970" href="https://doi.org/10.1002/1529-0131(200112)44:12<2777::AID-ART465&gt;3.0.CO;2-H">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d15654e1979 class=n-a></a>Sato T, Konomi K, Yamasaki S, <i> et al.</i>: Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilage. <i>Arthritis Rheum.</i> 2006; <b>54</b>(3): 80817. <a target=xrefwindow id=d15654e1990 href="http://www.ncbi.nlm.nih.gov/pubmed/16508957">PubMed Abstract </a> | <a target=xrefwindow id=d15654e1993 href="https://doi.org/10.1002/art.21638">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d15654e2003 class=n-a></a>Aigner T, Fundel K, Saas J, <i> et al.</i>: Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. <i>Arthritis Rheum.</i> 2006; <b>54</b>(11): 353344. <a target=xrefwindow id=d15654e2014 href="http://www.ncbi.nlm.nih.gov/pubmed/17075858">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2017 href="https://doi.org/10.1002/art.22174">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732345657"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e2026 class=n-a></a>Soul J, Dunn SL, Anand S, <i> et al.</i>: Stratification of knee osteoarthritis: Two major patient subgroups identified by genome-wide expression analysis of articular cartilage. <i>Ann Rheum Dis.</i> 2018; <b>77</b>(3): 423. <a target=xrefwindow id=d15654e2037 href="http://www.ncbi.nlm.nih.gov/pubmed/29273645">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2040 href="https://doi.org/10.1136/annrheumdis-2017-212603">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2044 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5867416">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732345657">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733672211"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e2057 class=n-a></a>Ji Q, Zheng Y, Zhang G, <i> et al.</i>: Single-cell RNA-seq analysis reveals the progression of human osteoarthritis. <i>Ann Rheum Dis.</i> 2018; <b>78</b>(1): 10010. <a target=xrefwindow id=d15654e2068 href="http://www.ncbi.nlm.nih.gov/pubmed/30026257">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2071 href="https://doi.org/10.1136/annrheumdis-2017-212863">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2075 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6317448">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733672211">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d15654e2088 class=n-a></a>Ryder JJ, Garrison K, Song F, <i> et al.</i>: Genetic associations in peripheral joint osteoarthritis and spinal degenerative disease: A systematic review. <i>Ann Rheum Dis.</i> 2008; <b>67</b>(5): 58491. <a target=xrefwindow id=d15654e2099 href="http://www.ncbi.nlm.nih.gov/pubmed/17720722">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2102 href="https://doi.org/10.1136/ard.2007.073874">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734895527"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e2111 class=n-a></a>Tachmazidou I, Hatzikotoulas K, Southam L, <i> et al.</i>: Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data. <i>Nat Genet.</i> 2019; <b>51</b>(2): 230236. <a target=xrefwindow id=d15654e2122 href="http://www.ncbi.nlm.nih.gov/pubmed/30664745">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2125 href="https://doi.org/10.1038/s41588-018-0327-1">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2129 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6400267">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734895527">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d15654e2142 class=n-a></a>Appleton CTG, Usmani SE, Pest MA, <i> et al.</i>: Reduction in disease progression by inhibition of transforming growth factor -CCL2 signaling in experimental posttraumatic osteoarthritis. <i>Arthritis Rheumatol.</i> 2015; <b>67</b>(10): 2691701. <a target=xrefwindow id=d15654e2153 href="http://www.ncbi.nlm.nih.gov/pubmed/26138996">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2156 href="https://doi.org/10.1002/art.39255">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d15654e2166 class=n-a></a>Dahlberg LE, Aydemir A, Muurahainen N, <i> et al.</i>: A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis. <i>Clin Exp Rheumatol.</i> 2016; <b>34</b>(3): 44550. <a target=xrefwindow id=d15654e2177 href="http://www.ncbi.nlm.nih.gov/pubmed/27050139">PubMed Abstract </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d15654e2186 class=n-a></a>Eckstein F, Wirth W, Guermazi A, <i> et al.</i>: Brief Report: Intraarticular Sprifermin Not Only Increases Cartilage Thickness, but Also Reduces Cartilage Loss: Location-Independent Post Hoc Analysis Using Magnetic Resonance Imaging. <i>Arthritis Rheumatol.</i> 2015; <b>67</b>(11): 291622. <a target=xrefwindow id=d15654e2197 href="http://www.ncbi.nlm.nih.gov/pubmed/26138203">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2200 href="https://doi.org/10.1002/art.39265">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2204 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5061102">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d15654e2213 class=n-a></a>Styrkarsdottir U, Thorleifsson G, Helgadottir HT, <i> et al.</i>: Severe osteoarthritis of the hand associates with common variants within the <i>ALDH1A2</i> gene and with rare variants at 1p31. <i>Nat Genet.</i> 2014; <b>46</b>(5): 498502. <a target=xrefwindow id=d15654e2227 href="http://www.ncbi.nlm.nih.gov/pubmed/24728293">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2231 href="https://doi.org/10.1038/ng.2957">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d15654e2240 class=n-a></a>Elsaid KA, Zhang L, Shaman Z, <i> et al.</i>: The impact of early intra-articular administration of interleukin-1 receptor antagonist on lubricin metabolism and cartilage degeneration in an anterior cruciate ligament transection model. <i>Osteoarthritis Cartilage.</i> 2015; <b>23</b>(1): 11421. <a target=xrefwindow id=d15654e2251 href="http://www.ncbi.nlm.nih.gov/pubmed/25219670">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2254 href="https://doi.org/10.1016/j.joca.2014.09.006">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2258 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4275352">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d15654e2267 class=n-a></a>Caron JP, Fernandes JC, Martel-Pelletier J, <i> et al.</i>: Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. <i>Arthritis Rheum.</i> 1996; <b>39</b>(9): 153544. <a target=xrefwindow id=d15654e2278 href="http://www.ncbi.nlm.nih.gov/pubmed/8814066">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2281 href="https://doi.org/10.1002/art.1780390914">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d15654e2290 class=n-a></a>Pelletier JP, Caron JP, Evans C, <i> et al.</i>: <i>In vivo</i> suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. <i>Arthritis Rheum.</i> 1997; <b>40</b>(6): 10129. <a target=xrefwindow id=d15654e2304 href="http://www.ncbi.nlm.nih.gov/pubmed/9182910">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2308 href="https://doi.org/10.1002/art.1780400604">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d15654e2318 class=n-a></a>Elsaid KA, Ubhe A, Shaman Z, <i> et al.</i>: Intra-articular interleukin-1 receptor antagonist (IL1-ra) microspheres for posttraumatic osteoarthritis: <i>In vitro</i> biological activity and <i>in vivo</i> disease modifying effect. <i>J Exp Orthop.</i> 2016; <b>3</b>(1): 18. <a target=xrefwindow id=d15654e2336 href="http://www.ncbi.nlm.nih.gov/pubmed/27539076">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2339 href="https://doi.org/10.1186/s40634-016-0054-4">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2342 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4990523">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d15654e2351 class=n-a></a>D'Lima D, Hermida J, Hashimoto S, <i> et al.</i>: Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. <i>Arthritis Rheum.</i> 2006; <b>54</b>(6): 181421. <a target=xrefwindow id=d15654e2362 href="http://www.ncbi.nlm.nih.gov/pubmed/16736522">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2365 href="https://doi.org/10.1002/art.21874">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d15654e2374 class=n-a></a>Clements KM, Price JS, Chambers MG, <i> et al.</i>: Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. <i>Arthritis Rheum.</i> 2003; <b>48</b>(12): 345263. <a target=xrefwindow id=d15654e2385 href="http://www.ncbi.nlm.nih.gov/pubmed/14673996">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2388 href="https://doi.org/10.1002/art.11355">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d15654e2397 class=n-a></a>Fukai A, Kamekura S, Chikazu D, <i> et al.</i>: Lack of a chondroprotective effect of cyclooxygenase 2 inhibition in a surgically induced model of osteoarthritis in mice. <i>Arthritis Rheum.</i> 2012; <b>64</b>(1): 198203. <a target=xrefwindow id=d15654e2408 href="http://www.ncbi.nlm.nih.gov/pubmed/21905007">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2411 href="https://doi.org/10.1002/art.33324">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d15654e2420 class=n-a></a>Glasson SS: <i>In Vivo</i> Osteoarthritis Target Validation Utilizing Genetically-Modified Mice. <i>Curr Drug Targets.</i> 2007; <b>8</b>(2): 36776. <a target=xrefwindow id=d15654e2431 href="http://www.ncbi.nlm.nih.gov/pubmed/17305514">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2434 href="https://doi.org/10.2174/138945007779940061">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d15654e2443 class=n-a></a>Bacconnier L, Jorgensen C, Fabre S: Erosive osteoarthritis of the hand: Clinical experience with anakinra. <i>Ann Rheum Dis.</i> 2009; <b>68</b>(6): 10789. <a target=xrefwindow id=d15654e2451 href="http://www.ncbi.nlm.nih.gov/pubmed/19435727">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2454 href="https://doi.org/10.1136/ard.2008.094284">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734638833"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e2464 class=n-a></a>Kloppenburg M, Peterfy C, Haugen IK, <i> et al.</i>: Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1 and anti-interleukin-1 dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis. <i>Ann Rheum Dis.</i> 2019; <b>78</b>(3): 413420. <a target=xrefwindow id=d15654e2475 href="http://www.ncbi.nlm.nih.gov/pubmed/30552176">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2478 href="https://doi.org/10.1136/annrheumdis-2018-213336">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2482 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6390132">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734638833">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d15654e2495 class=n-a></a>Fleischmann RM, Bliddal H, Blanco FJ, <i> et al.</i>: A Phase II Trial of Lutikizumab, an Anti-Interleukin 1/ Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis. <i>Arthritis Rheumatol.</i> 2019. <a target=xrefwindow id=d15654e2503 href="http://www.ncbi.nlm.nih.gov/pubmed/30653843">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2506 href="https://doi.org/10.1002/art.40840">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d15654e2515 class=n-a></a>Chevalier X, Goupille P, Beaulieu AD, <i> et al.</i>: Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double-blind, placebo-controlled study. <i>Arthritis Rheum.</i> 2009; <b>61</b>(3): 34452. <a target=xrefwindow id=d15654e2526 href="http://www.ncbi.nlm.nih.gov/pubmed/19248129">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2529 href="https://doi.org/10.1002/art.24096">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d15654e2538 class=n-a></a>Cohen SB, Proudman S, Kivitz AJ, <i> et al.</i>: A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. <i>Arthritis Res Ther.</i> 2011; <b>13</b>(4): R125. <a target=xrefwindow id=d15654e2549 href="http://www.ncbi.nlm.nih.gov/pubmed/21801403">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2552 href="https://doi.org/10.1186/ar3430">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2556 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3239365">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d15654e2565 class=n-a></a>Lohmander LS, Englund PM, Dahl LL, <i> et al.</i>: The long-term consequence of anterior cruciate ligament and meniscus injuries: Osteoarthritis. <i>Am J Sports Med.</i> 2007; <b>35</b>(10): 175669. <a target=xrefwindow id=d15654e2576 href="http://www.ncbi.nlm.nih.gov/pubmed/17761605">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2579 href="https://doi.org/10.1177/0363546507307396">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d15654e2588 class=n-a></a>Kraus VB, Birmingham J, Stabler TV, <i> et al.</i>: Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). <i>Osteoarthritis Cartilage.</i> 2012; <b>20</b>(4): 2718. <a target=xrefwindow id=d15654e2599 href="http://www.ncbi.nlm.nih.gov/pubmed/22273632">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2602 href="https://doi.org/10.1016/j.joca.2011.12.009">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d15654e2612 class=n-a></a>Brown C, Toth A, Magnussen R: Clinical Benefits of Intra-articular Anakinra for Persistent Knee Effusion. <i>J Knee Surg.</i> 2011; <b>24</b>(1): 616. <a target=xrefwindow id=d15654e2620 href="http://www.ncbi.nlm.nih.gov/pubmed/21618940">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2623 href="https://doi.org/10.1055/s-0031-1275398">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d15654e2632 class=n-a></a>Frallonardo P, Ramonda R, Peruzzo L, <i> et al.</i>: Basic calcium phosphate and pyrophosphate crystals in early and late osteoarthritis: Relationship with clinical indices and inflammation. <i>Clin Rheumatol.</i> 2018; <b>37</b>(10): 28472853. <a target=xrefwindow id=d15654e2643 href="http://www.ncbi.nlm.nih.gov/pubmed/29882204">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2646 href="https://doi.org/10.1007/s10067-018-4166-3">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d15654e2655 class=n-a></a>Galozzi P, Oliviero F, Frallonardo P, <i> et al.</i>: The prevalence of monosodium urate and calcium pyrophosphate crystals in synovial fluid from wrist and finger joints. <i>Rheumatol Int.</i> 2016; <b>36</b>(3): 4436. <a target=xrefwindow id=d15654e2666 href="http://www.ncbi.nlm.nih.gov/pubmed/26440935">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2669 href="https://doi.org/10.1007/s00296-015-3376-0">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8153"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e2678 class=n-a></a>Martinon F, Ptrilli V, Mayor A, <i> et al.</i>: Gout-associated uric acid crystals activate the NALP3 inflammasome. <i>Nature.</i> 2006; <b>440</b>(7081): 23741. <a target=xrefwindow id=d15654e2689 href="http://www.ncbi.nlm.nih.gov/pubmed/16407889">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2692 href="https://doi.org/10.1038/nature04516">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8153">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d15654e2705 class=n-a></a>Jin C, Frayssinet P, Pelker R, <i> et al.</i>: NLRP3 inflammasome plays a critical role in the pathogenesis of hydroxyapatite-associated arthropathy. <i>Proc Natl Acad Sci U S A.</i> 2011; <b>108</b>(36): 1486772. <a target=xrefwindow id=d15654e2716 href="http://www.ncbi.nlm.nih.gov/pubmed/21856950">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2719 href="https://doi.org/10.1073/pnas.1111101108">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2723 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3169126">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/3259957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d15654e2732 class=n-a></a>Duewell P, Kono H, Rayner KJ, <i> et al.</i>: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. <i>Nature.</i> 2010; <b>464</b>(7293): 135761. <a target=xrefwindow id=d15654e2743 href="http://www.ncbi.nlm.nih.gov/pubmed/20428172">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2746 href="https://doi.org/10.1038/nature08938">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2750 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2946640">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/3259957">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d15654e2764 class=n-a></a>Olmez N, Schumacher HR Jr: Crystal deposition and osteoarthritis. <i>Curr Rheumatol Rep.</i> 1999; <b>1</b>(2): 10711. <a target=xrefwindow id=d15654e2772 href="http://www.ncbi.nlm.nih.gov/pubmed/11123023">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2775 href="https://doi.org/10.1007/s11926-999-0006-4">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d15654e2784 class=n-a></a>Kuemmerle-Deschner JB, Hachulla E, Cartwright R, <i> et al.</i>: Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes. <i>Ann Rheum Dis.</i> 2011; <b>70</b>(12): 2095102. <a target=xrefwindow id=d15654e2795 href="http://www.ncbi.nlm.nih.gov/pubmed/21859692">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2798 href="https://doi.org/10.1136/ard.2011.152728">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d15654e2807 class=n-a></a>Dinarello CA: How interleukin-1 induces gouty arthritis. <i>Arthritis Rheum.</i> 2010; <b>62</b>(11): 31404. <a target=xrefwindow id=d15654e2815 href="http://www.ncbi.nlm.nih.gov/pubmed/20662058">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2818 href="https://doi.org/10.1002/art.27663">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2821 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3534984">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d15654e2830 class=n-a></a>Vincent T, Malfait AM: Time to be positive about negative data? <i>Osteoarthritis Cartilage.</i> 2017; <b>25</b>(3): 351353. <a target=xrefwindow id=d15654e2838 href="http://www.ncbi.nlm.nih.gov/pubmed/28224967">PubMed Abstract </a> | <a target=xrefwindow id=d15654e2841 href="https://doi.org/10.1016/j.joca.2017.01.016">Publisher Full Text </a> | <a target=xrefwindow id=d15654e2844 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6034630">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (1)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class=comments-list-container> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class="mversion ">VERSION 1</span> <span class="details u-ml--1">PUBLISHED 21 Jun 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <ul class=all-comment-wrapper data-reportID=NONE data-versionID=1> <li class="comment-wrapper not-sortable " data-commentID=4711> <div class="one-comment version-comments "> <a name=article-comment-4711></a> <div class="f1r-article-desk commenter-role"> Reader Comment 28 Jun 2019 </div> <div> <span class=name>Timothy Hardingham</span><span class=name>, </span><span class=commenter-affiliation>Prof Tim Hardingham, Wellcome Centre for Cell-Matrix Research, University of Manchester, UK</span> </div> <div class="f1r-article-mobile the-comment-date"> 28 Jun 2019 </div> <div class=f1r-article-mobile> <div class="article-pubinfo-mobile comments-section"> <span class="version-info-box comments"> Reader Comment </span> </div> </div> <div class="comment-content article-comment-list"> <span class=truncated-comment> This an extremely timely review that questions a commonly held assumption that because IL1 can drive inflammation and cause the degradation of articular cartilage it must be responsible in vivo ... <span class="continue-reading-container response-and-comment">Continue reading</span> </span> <span class="full-comment hidden"> <span id=full-comment-original-4711 class=hidden>This an extremely timely review that questions a commonly held assumption that because IL1 can drive inflammation and cause the degradation of articular cartilage it must be responsible in vivo for the damage to cartilage in osteoarthritis. Examination of the background literature, as Tonia Vincent has done, reveals the flimsiest evidence that IL1 is active in most osteoarthritic joints and more recent holistic analysis, such as our RNAseq study of OA and non-OA cartilage (Soul et al Ann Rheum Dis 2018), showed no detectible expression in 60 OA knees at TKR&nbsp; and no evidence of cartilage responding to IL1 in synovial fluid, again in all patients. Tonias review of IL1 in my view could be easily extended to TNF (and OSM), which have a similar profile of limited evidence in vivo in OA.<br/> <br/> Are there OA joints in which IL1/TNF/OSM might play a part? As the review suggests, undoubtedly there are, as OA is a heterogeneous disease with many factors involved. The point is that these joints and/or these patients are the exceptions and targeting these pathways as pathogenic in all OA is a lost cause. As a research community we need to wise up and not perpetuate this myth and concentrate instead on the range of other genetic and environmental factors that predispose joints to irreversible damage and loss of function and develop methods to stratify OA to identify the subsets that will respond to specific modes of intervention.</span> <div class=padding-bottom id=full-comment-4711>This an extremely timely review that questions a commonly held assumption that because IL1 can drive inflammation and cause the degradation of articular cartilage it must be responsible in vivo for the damage to cartilage in osteoarthritis. Examination of the background literature, as Tonia Vincent has done, reveals the flimsiest evidence that IL1 is active in most osteoarthritic joints and more recent holistic analysis, such as our RNAseq study of OA and non-OA cartilage (Soul et al Ann Rheum Dis 2018), showed no detectible expression in 60 OA knees at TKR&nbsp; and no evidence of cartilage responding to IL1 in synovial fluid, again in all patients. Tonias review of IL1 in my view could be easily extended to TNF (and OSM), which have a similar profile of limited evidence in vivo in OA.<br/> <br/> Are there OA joints in which IL1/TNF/OSM might play a part? As the review suggests, undoubtedly there are, as OA is a heterogeneous disease with many factors involved. The point is that these joints and/or these patients are the exceptions and targeting these pathways as pathogenic in all OA is a lost cause. As a research community we need to wise up and not perpetuate this myth and concentrate instead on the range of other genetic and environmental factors that predispose joints to irreversible damage and loss of function and develop methods to stratify OA to identify the subsets that will respond to specific modes of intervention.</div> <span class="disclosures competing-interests-display padding-top"> <strong>Competing Interests:</strong> <span class=c-i-d>No competing interests</span> </span> <span class="hide-comment-container response-and-comment">Close</span> </span> <div class="report-concern-wrapper last-comment"> <a href="mailto:research@f1000.com?subject=Report a concern (18831) " class=report-a-concern-link>Report a concern</a> </div> </div> </div> </li> <li class="comment-wrapper not-sortable button-wrapper"> <div class="one-comment version-comments add-the-comment"> <a href="/login?originalPath=/articles/8-934/v1&scrollTo=add-new-comments" class=register-report-comment-button data-test-id=add-comment> <span class=f1r-article-desk><span class=contracted></span>Comment</span> <span class="f1r-article-mobile research-layout "> <button class="primary orange extra-padding comment-on-this-article">ADD YOUR COMMENT</button> </span> </a> </div> </li> </ul> </div> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Centre for OA Pathogenesis Versus Arthritis, Kennedy Institute of Rheumatology, University of Oxford, Oxford, OX3 7FY, UK<br/> <p> <div class=margin-bottom> Tonia L. Vincent <br/> <span>Roles: </span> Conceptualization, Data Curation, Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-934/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 21 Jun 2019, 8:934 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.18831.1">https://doi.org/10.12688/f1000research.18831.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2019 Vincent TL. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=20635 data-id=18831 data-downloads="" data-views="" data-scholar="10.12688/f1000research.18831.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-934/v1/pdf?article_uuid=13040baa-4d50-4d03-8965-880ced5493e8" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.18831.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Vincent TL. IL-1 in osteoarthritis: time for a critical review of the literature [version 1; peer review: 2 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):934 (<a href="https://doi.org/10.12688/f1000research.18831.1" target=_blank>https://doi.org/10.12688/f1000research.18831.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=18831 id=mobile-track-article-signin-18831 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/18831?target=/articles/8-934/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=20635 /> <input name=articleId type=hidden value=18831 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Tariq M. Haqqi</strong>, Department of Anatomy and Neurobiology, Northeast Ohio Medical University, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Charles J. Malemud</strong>, Division of Rheumatic Diseases, Case Western Reserve University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (1)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class=comments-list-container> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class="mversion ">VERSION 1</span> <span class=details>PUBLISHED 21 Jun 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <ul class=all-comment-wrapper data-reportID=NONE data-versionID=1> <li class="comment-wrapper not-sortable " data-commentID=4711> <div class="one-comment version-comments "> <a name=article-comment-4711></a> <div class="f1r-article-desk commenter-role"> Reader Comment 28 Jun 2019 </div> <div> <span class=name>Timothy Hardingham</span><span class=name>, </span><span class=commenter-affiliation>Prof Tim Hardingham, Wellcome Centre for Cell-Matrix Research, University of Manchester, UK</span> </div> <div class="f1r-article-mobile the-comment-date"> 28 Jun 2019 </div> <div class=f1r-article-mobile> <div class="article-pubinfo-mobile comments-section"> <span class="version-info-box comments"> Reader Comment </span> </div> </div> <div class="comment-content article-comment-list"> <span class=truncated-comment> This an extremely timely review that questions a commonly held assumption that because IL1 can drive inflammation and cause the degradation of articular cartilage it must be responsible in vivo ... <span class="continue-reading-container response-and-comment">Continue reading</span> </span> <span class="full-comment hidden"> <span id=full-comment-original-4711 class=hidden>This an extremely timely review that questions a commonly held assumption that because IL1 can drive inflammation and cause the degradation of articular cartilage it must be responsible in vivo for the damage to cartilage in osteoarthritis. Examination of the background literature, as Tonia Vincent has done, reveals the flimsiest evidence that IL1 is active in most osteoarthritic joints and more recent holistic analysis, such as our RNAseq study of OA and non-OA cartilage (Soul et al Ann Rheum Dis 2018), showed no detectible expression in 60 OA knees at TKR&nbsp; and no evidence of cartilage responding to IL1 in synovial fluid, again in all patients. Tonias review of IL1 in my view could be easily extended to TNF (and OSM), which have a similar profile of limited evidence in vivo in OA.<br/> <br/> Are there OA joints in which IL1/TNF/OSM might play a part? As the review suggests, undoubtedly there are, as OA is a heterogeneous disease with many factors involved. The point is that these joints and/or these patients are the exceptions and targeting these pathways as pathogenic in all OA is a lost cause. As a research community we need to wise up and not perpetuate this myth and concentrate instead on the range of other genetic and environmental factors that predispose joints to irreversible damage and loss of function and develop methods to stratify OA to identify the subsets that will respond to specific modes of intervention.</span> <div class=padding-bottom id=full-comment-4711>This an extremely timely review that questions a commonly held assumption that because IL1 can drive inflammation and cause the degradation of articular cartilage it must be responsible in vivo for the damage to cartilage in osteoarthritis. Examination of the background literature, as Tonia Vincent has done, reveals the flimsiest evidence that IL1 is active in most osteoarthritic joints and more recent holistic analysis, such as our RNAseq study of OA and non-OA cartilage (Soul et al Ann Rheum Dis 2018), showed no detectible expression in 60 OA knees at TKR&nbsp; and no evidence of cartilage responding to IL1 in synovial fluid, again in all patients. Tonias review of IL1 in my view could be easily extended to TNF (and OSM), which have a similar profile of limited evidence in vivo in OA.<br/> <br/> Are there OA joints in which IL1/TNF/OSM might play a part? As the review suggests, undoubtedly there are, as OA is a heterogeneous disease with many factors involved. The point is that these joints and/or these patients are the exceptions and targeting these pathways as pathogenic in all OA is a lost cause. As a research community we need to wise up and not perpetuate this myth and concentrate instead on the range of other genetic and environmental factors that predispose joints to irreversible damage and loss of function and develop methods to stratify OA to identify the subsets that will respond to specific modes of intervention.</div> <span class="disclosures competing-interests-display padding-top"> <strong>Competing Interests:</strong> <span class=c-i-d>No competing interests</span> </span> <span class="hide-comment-container response-and-comment">Close</span> </span> <div class="report-concern-wrapper last-comment"> <a href="mailto:research@f1000.com?subject=Report a concern (18831) " class=report-a-concern-link>Report a concern</a> </div> </div> </div> </li> <li class="comment-wrapper not-sortable button-wrapper"> <div class="one-comment version-comments add-the-comment"> <a href="/login?originalPath=/articles/8-934/v1&scrollTo=add-new-comments" class=register-report-comment-button data-test-id=add-comment> <span class=f1r-article-desk><span class=contracted></span>Comment</span> <span class="f1r-article-mobile research-layout "> <button class="primary orange extra-padding comment-on-this-article">ADD YOUR COMMENT</button> </span> </a> </div> </li> </ul> </div> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=52630-49915></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=52629-49916></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-934/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>21 Jun 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Tariq M. Haqqi</strong>, Department of Anatomy and Neurobiology, Northeast Ohio Medical University, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Charles J. Malemud</strong>, Division of Rheumatic Diseases, Case Western Reserve University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(1)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-934/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-934/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "IL-1 in osteoarthritis: time for a critical...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-934/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-934/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-934/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Vincent TL');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-934/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-934",
            templates : {
                twitter : "IL-1 in osteoarthritis: time for a critical review of the literature. Vincent TL, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-934/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: IL-1 in osteoarthritis: time for a critical review of the literature", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: IL-1 in osteoarthritis: time for a critical review of the literature", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/18831/20635")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "20635");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "49915": 0,
                           "49916": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "67b59af2-eecd-47b4-a6cf-133e59c37bb5";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-934.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-934.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-934.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-934.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-934.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>